• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解决铁稳态机制和缺铁性疾病。

Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.

出版信息

J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI148671.

DOI:10.1172/JCI148671
PMID:34060484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159681/
Abstract

Iron plays an important role in mammalian physiological processes. It is a critical component for the function of many proteins, including enzymes that require heme and iron-sulfur clusters. However, excess iron is also detrimental because of its ability to catalyze the formation of reactive oxygen species. As a result, cellular and systemic iron levels are tightly regulated to prevent oxidative damage. Iron deficiency can lead to a number of pathological conditions, the most prominent being anemia. Iron deficiency should be corrected to improve adult patients' symptoms and to facilitate normal growth during fetal development and childhood. However, inappropriate use of intravenous iron in chronic conditions, such as cancer and heart failure, in the absence of clear iron deficiency can lead to unwanted side effects. Thus, this form of therapy should be reserved for certain patients who cannot tolerate oral iron and need rapid iron replenishment. Here, we will review cellular and systemic iron homeostasis and will discuss complications of iron deficiency.

摘要

铁在哺乳动物生理过程中起着重要作用。它是许多蛋白质功能的关键组成部分,包括需要血红素和铁硫簇的酶。然而,过量的铁也有危害,因为它能够催化活性氧的形成。因此,细胞和全身的铁水平受到严格调节,以防止氧化损伤。铁缺乏可导致多种病理状况,最突出的是贫血。为了改善成年患者的症状并促进胎儿发育和儿童期的正常生长,应纠正铁缺乏。然而,在没有明确铁缺乏的情况下,在癌症和心力衰竭等慢性疾病中不恰当地使用静脉铁会导致不必要的副作用。因此,这种治疗形式应保留给那些不能耐受口服铁且需要快速补铁的特定患者。在这里,我们将回顾细胞和全身铁稳态,并讨论铁缺乏的并发症。

相似文献

1
Ironing out mechanisms of iron homeostasis and disorders of iron deficiency.解决铁稳态机制和缺铁性疾病。
J Clin Invest. 2021 Jun 1;131(11). doi: 10.1172/JCI148671.
2
Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets.铁代谢与心血管疾病:生理、机制与治疗靶点。
Circ Res. 2023 Feb 3;132(3):379-396. doi: 10.1161/CIRCRESAHA.122.321667. Epub 2023 Feb 2.
3
[Iron deficiency in heart failure: beyond the anemia.].[心力衰竭中的缺铁:超越贫血。]
Recenti Prog Med. 2020 Jul-Aug;111(7):444-453. doi: 10.1701/3407.33926.
4
Treatment with iron of patients with heart failure with and without anemia.铁剂治疗伴或不伴贫血的心力衰竭患者。
Heart Fail Clin. 2010 Jul;6(3):305-12. doi: 10.1016/j.hfc.2010.02.002.
5
Extending the Evidence for Intravenous Iron in Patients With Heart Failure and Iron Deficiency.扩大心力衰竭合并缺铁患者静脉补铁的证据
JACC Heart Fail. 2024 Mar;12(3):537-538. doi: 10.1016/j.jchf.2023.12.002. Epub 2024 Jan 10.
6
Iron deficiency and supplementation in heart failure.心力衰竭中的铁缺乏与补充。
Nat Rev Cardiol. 2024 Jul;21(7):463-486. doi: 10.1038/s41569-024-00988-1. Epub 2024 Feb 7.
7
[Iron deficiency in patients with acute and chronic heart failure - a simple algoritm].[急性和慢性心力衰竭患者的缺铁——一种简单的算法]
Lakartidningen. 2022 Sep 21;119:22014.
8
Influence of mitochondrial and systemic iron levels in heart failure pathology.线粒体和全身铁水平对心力衰竭病理的影响。
Heart Fail Rev. 2019 Sep;24(5):647-659. doi: 10.1007/s10741-019-09788-z.
9
Intravenous iron therapy in pediatrics: who should get it and when is the right time?儿科静脉铁治疗:谁应该接受治疗,何时是最佳时机?
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):630-635. doi: 10.1182/hematology.2023000496.
10
Parenteral Iron in Heart Failure: An Indian Perspective.心力衰竭的静脉铁剂治疗:印度视角。
J Assoc Physicians India. 2022 Feb;70(2):11-12.

引用本文的文献

1
Iron overload promotes myeloid differentiation of normal hematopoietic stem cells and educates macrophage mediated immunosuppression in acute myeloid leukemia.铁过载促进正常造血干细胞的髓系分化,并在急性髓系白血病中诱导巨噬细胞介导的免疫抑制。
Front Immunol. 2025 Aug 13;16:1626888. doi: 10.3389/fimmu.2025.1626888. eCollection 2025.
2
Unlocking iron: nutritional origins, metabolic pathways, and systemic significance.释放铁元素:营养来源、代谢途径及全身意义
Front Nutr. 2025 Aug 13;12:1637316. doi: 10.3389/fnut.2025.1637316. eCollection 2025.
3
Predictive machine-learning model for screening iron deficiency without anaemia: a retrospective cohort study.用于筛查非贫血性缺铁的预测性机器学习模型:一项回顾性队列研究。
BMJ Open. 2025 Aug 12;15(8):e097016. doi: 10.1136/bmjopen-2024-097016.
4
Parkin inhibits iron overload-induced cardiomyocyte ferroptosis by ubiquitinating ACSL4 and modulating PUFA-phospholipids metabolism.帕金通过泛素化ACSL4和调节多不饱和脂肪酸-磷脂代谢来抑制铁过载诱导的心肌细胞铁死亡。
Acta Pharm Sin B. 2025 Mar;15(3):1589-1607. doi: 10.1016/j.apsb.2024.12.027. Epub 2025 Jan 2.
5
A metal-polyphenol network-based iron supplement with improved stability and reduced gastrointestinal toxicity for iron deficiency anemia therapy.一种基于金属-多酚网络的铁补充剂,具有改善的稳定性并降低了胃肠道毒性,用于缺铁性贫血治疗。
Mater Today Bio. 2025 Feb 20;31:101598. doi: 10.1016/j.mtbio.2025.101598. eCollection 2025 Apr.
6
Iron and ferroptosis in kidney disease: molecular and metabolic mechanisms.铁与肾脏疾病中的铁死亡:分子与代谢机制
Front Immunol. 2025 Feb 5;16:1531577. doi: 10.3389/fimmu.2025.1531577. eCollection 2025.
7
Ferroptosis: mechanism and role in diabetes-related cardiovascular diseases.铁死亡:在糖尿病相关心血管疾病中的机制及作用
Cardiovasc Diabetol. 2025 Feb 7;24(1):60. doi: 10.1186/s12933-025-02614-x.
8
Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase.阿霉素诱导的迟发性心脏毒性理论的演变——拓扑异构酶的作用
Int J Mol Sci. 2024 Dec 18;25(24):13567. doi: 10.3390/ijms252413567.
9
Interactions between ferroptosis and tumour development mechanisms: Implications for gynaecological cancer therapy (Review).铁死亡与肿瘤发生机制之间的相互作用:对妇科癌症治疗的启示(综述)
Oncol Rep. 2025 Feb;53(2). doi: 10.3892/or.2024.8851. Epub 2024 Dec 5.
10
Absolute versus functional iron deficiency.绝对缺铁与功能性缺铁
Clin Exp Pediatr. 2025 Feb;68(2):138-140. doi: 10.3345/cep.2023.01732. Epub 2024 Nov 13.

本文引用的文献

1
Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice.自噬介导线粒体铁蛋白降解导致小鼠心肌细胞死亡和心力衰竭。
Elife. 2021 Feb 2;10:e62174. doi: 10.7554/eLife.62174.
2
Oral sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: a non-randomized, open-label, proof-of-concept study.口服蔗糖铁可改善射血分数降低和缺铁性心力衰竭患者的运动能力和生活质量:一项非随机、开放标签、概念验证研究。
Eur J Heart Fail. 2021 Apr;23(4):593-597. doi: 10.1002/ejhf.2092. Epub 2021 Jan 22.
3
Iron and Chronic Kidney Disease: Still a Challenge.铁与慢性肾脏病:仍是一项挑战。
Front Med (Lausanne). 2020 Dec 18;7:565135. doi: 10.3389/fmed.2020.565135. eCollection 2020.
4
Erythroferrone structure, function, and physiology: Iron homeostasis and beyond.促红细胞生成素铁蛋白结构、功能和生理学:铁稳态及其以外。
J Cell Physiol. 2021 Jul;236(7):4888-4901. doi: 10.1002/jcp.30247. Epub 2020 Dec 28.
5
Iron: An Essential Element of Cancer Metabolism.铁:癌症代谢的必需元素。
Cells. 2020 Dec 3;9(12):2591. doi: 10.3390/cells9122591.
6
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.齐特利单抗治疗血液透析患者炎症性贫血的 1/2 期多中心、随机、双盲、安慰剂对照试验结果。
J Am Soc Nephrol. 2021 Jan;32(1):211-222. doi: 10.1681/ASN.2020050595. Epub 2020 Dec 3.
7
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.铁羧基麦芽糖治疗急性心力衰竭出院后缺铁:一项多中心、双盲、随机、对照试验。
Lancet. 2020 Dec 12;396(10266):1895-1904. doi: 10.1016/S0140-6736(20)32339-4. Epub 2020 Nov 13.
8
Severe Symptomatic Hypophosphataemia as a Complication of Parenteral Iron Replacement.严重症状性低磷血症作为肠外铁剂替代治疗的一种并发症
Eur J Case Rep Intern Med. 2020 Aug 20;7(11):001860. doi: 10.12890/2020_001860. eCollection 2020.
9
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis.静脉注射羧基麦芽糖铁或异麦芽糖铁治疗缺铁后低磷血症的系统评价和荟萃分析。
Br J Clin Pharmacol. 2021 May;87(5):2256-2273. doi: 10.1111/bcp.14643. Epub 2020 Dec 7.
10
Evolution of the human mitochondrial ABCB7 [2Fe-2S](GS) cluster exporter and the molecular mechanism of an E433K disease-causing mutation.人类线粒体 ABCB7 [2Fe-2S](GS) 簇外排蛋白的进化和 E433K 致病突变的分子机制。
Arch Biochem Biophys. 2021 Jan 15;697:108661. doi: 10.1016/j.abb.2020.108661. Epub 2020 Nov 3.